+499.5%
MRNA vs FBTC
-28.2%
+527.7%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | FBTC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -2.5% | +0.3% | -0.1% |
| 7D | +5.5% | +2.9% | +2.6% | +2.4% |
| 30D | +158.7% | +23.0% | +135.7% | +116.3% |
| 3M | +182.1% | +25.6% | +156.5% | +133.4% |
| 6M | +151.8% | +9.0% | +142.8% | +119.4% |
| YTD | +393.6% | -8.9% | +402.5% | +354.2% |
| 1Y | +499.5% | -27.5% | +527.0% | +482.9% |
| All | +499.5% | -28.2% | +527.7% | +482.9% |
Cumulative growth
Daily Returns
Daily percentage return beside FBTC.
Daily Out/Under-Performance
Portfolio return minus FBTC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × FBTC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded FBTC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling